Recap: Immunogen Q3 Earnings

Immunogen IMGN reported its Q3 earnings results on Friday, November 4, 2022 at 06:30 AM.

Here's what investors need to know about the announcement.

Earnings

Immunogen missed estimated earnings by 24.0%, reporting an EPS of $-0.31 versus an estimate of $-0.25.

Revenue was up $6.17 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.03 which was followed by a 9.71% drop in the share price the next day.

Here's a look at Immunogen's past performance:

 

Quarter Q2 2022 Q1 2022 Q4 2021 Q3 2021
EPS Estimate -0.21 -0.21 -1.71 -0.18
EPS Actual -0.24 -0.10 -0.17 -0.18
Revenue Estimate 16.18M 21.47M 25.65M 19.03M
Revenue Actual 14.16M 38.08M 27.99M 9.21M

To track all earnings releases for Immunogen visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!